<DOC>
	<DOCNO>NCT00541229</DOCNO>
	<brief_summary>A study ass safety efficacy sitagliptin 100mg compare sitagliptin 200mg patient type 2 diabetes .</brief_summary>
	<brief_title>Sitagliptin Dose Comparison Study Patients With Type 2 Diabetes ( MK-0431-077 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient Type 2 Diabetes Patient age 3065 year Patient antihyperglycemic agent ( AHA ) ( glycosylated hemoglobin [ A1C ] 710 % ) , oral single AHA lowdose combination therapy ( A1C 6.59.5 % ) . Patient Type 1 Diabetes Patient treat sitagliptin , vildagliptin , similar drug treat exenatide past 3 month Patient take insulin within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>